This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
What's Ahead for Marijuana ETFs After a Dismal Show in 2019?
by Sanghamitra Saha
Marijuana ETFs hit a high in 2018 only to experience a bloodbath in 2019. Let's see what lies in store for the space in 2020.
Is REX Shares' Leveraged Cannabis ETN Launch Untimely?
by Sanghamitra Saha
REX Shares has launched two cannabis-related ETNs, one among which is double leveraged. Is the launch untimely?
Top ETF Stories of November
by Sanghamitra Saha
Inside the key ETF events of the month of November.
Cannabis ETFs in Focus on Thanksgiving Weekend
by Sweta Killa
Cannabis spending rises over the Thanksgiving holiday period, especially Green Wednesday as well as on Black Friday.
Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?
by Sanghamitra Saha
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback?
by Benjamin Rains
Should investors think about buying some shares of Cronos (CRON) ahead of earnings, as a bet on a marijuana market comeback?
Should You Buy the Dip in Marijuana ETFs Ahead of Earnings?
by Sanghamitra Saha
Hexo's downbeat results weigh on marijuana space but many key pot companies are likely to beat in November. This could provide a good entry points to pot ETFs.
How to Invest in Emerging Industries Like Marijuana
by Tracey Ryniec
Investors are still crazy about the pot stocks despite this year's roller coaster ride.
Reefer Madness: Breaking Down The Current Cannabis Industry
by Panel Of Zacks Experts
Today we are joined by David Borun to discuss everything we need to know about the marijuana industry.
ETF Frenzy: Everything You Need To Know
by Panel Of Zacks Experts
Zacks' Resident ETF Expert, Neena Mishra, joins us to help teaches us about ETFs, ETNs and mutual funds
Top & Flop ETFs of Last Week
by Sweta Killa
Wall Street logged in the first weekly decline of a month. Inside the best and worst performing ETFs.
One More Marijuana ETF on the Block
by Sanghamitra Saha
As Global X launches a fresh pot ETF, let's explore the product in detail.
Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?
by Benjamin Rains
Despite growing sales and wider legalization, many pot stocks have been insanely volatile as Wall Street and investors try to wrap their heads around the marijuana industry. So should you think about buying "cheap" Aurora Cannabis (ACB) Stock before Q4 earnings?
5 ETFs Surge With Wall Street on Trade Talk Hopes
by Sweta Killa
We have highlighted five ETFs that gained most with the Wall Street rebound on Sep 5.
Spooked About Recessionary Fears? Bet on Sin Stocks & ETFs
by Sanghamitra Saha
These sin stocks and ETFs may prove to be recession-proof.
ETF Winners & Losers of Last Week
by Sweta Killa
We have highlighted last week's best and worst performing ETFs.
Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF
by Neena Mishra
CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.
Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF
by Neena Mishra
CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.
ETFs in Focus as Consolidation Drives Marijuana Industry
by Sanghamitra Saha
Deals activity has been robust in the marijuana space, paving way for gains in these cannabis ETFs.
2 Marijuana Stocks to Buy Heading into Q2 Earnings and Beyond
by Mitchell Moore
The marijuana industry is projected to grow at an annual rate of about 17% until it reaches $55.8 billion a year in 2025. The cannabis market has roughly tracked the S&P 500' s expansion in 2019 so far.
Marijuana & Blockchain ETFs: Should You Buy?
by Neena Mishra
Cannabis and blockchain are high-risk, high-reward areas of the market. Should investors consider these ETFs?
Marijuana ETF Space Gets Packed
by Sanghamitra Saha
The month of July has seen two marijuana ETF launches with the latest being from Amplify ETFs.
Zacks Market Edge Highlights: MJ, YOLO, THCX, TLRY and CRON
by Zacks Equity Research
Zacks Market Edge Highlights: MJ, YOLO, THCX, TLRY and CRON
Can We Find The Right Stock Using Our Newly Found Insight?
by Panel Of Zacks Experts
Can We Find The Right Stock Using Our Newly Found Insight?
Should You Buy a Cannabis ETF?
by Tracey Ryniec
There are now 3 pot ETFs with several more to launch soon. Is this a good way for investors to get exposure to the cannabis industry?